A wealth of structural information is now available on neutralizing antibodies from COVID-19 CPs bound to the SARS-CoV-2 spike trimer or receptor-binding domain (RBD) (>200 Protein Data Bank depositions), resulting in a highly detailed picture of the B cell response to this virus37–40. This evidence concerns the gene CAD and COVID-19.